Dernière mise à jour : juin 9, 2026
Female urinary retention is a rare condition compared to males — literature shows an incidence ratio of female to male as low as 1:13. The reason is that women do not have a prostate gland, which is the most common cause of bladder outlet obstruction in aging men. However, when acute urinary retention (AUR) does occur in a female, it presents a complex diagnostic and management challenge even for experienced physicians.
- Centre d'urologie Hôpital de Bangkok Thaïlande Réservation en ligne 02-310-3009 bhquro@bdms.co.th
- Hôpital Samitivej Sriracha Chonburi 088-022-1445

The etiology of female urinary retention is almost always multifactorial, requiring careful step-by-step assessment. I categorize the management into two clinical episodes.

Two clinical episodes of female urinary retention
- Acute episode — First presentation or symptoms present for less than 6 weeks. This is treated as a potentially reversible condition, and the priority is identifying and correcting the underlying cause. Common acute triggers include the postpartum period and urological anti-incontinence surgery.
- Chronic episode — Urinary retention that persists even after correctable causes have been addressed. Causes are divided into:
- Bladder causes — neurogenic bladder, underactive detrusor
- Bladder outlet obstruction — gynecological tumors, urethral tumors, or pregnancy

The immediate management for AUR in any patient is bladder decompression. When the bladder is overdistended beyond its functional limit, the surrounding nerve fibers become injured and require a period of rest to recover their contractile function.
Step-by-step management of female AUR
- Immediate bladder decompression via urethral catheterization or clean intermittent catheterization (CIC)
- Identify and correct the underlying etiology
- Continue bladder decompression for 1–14 days to allow bladder recovery, then trial of voiding
- If voiding trial succeeds, continue monitoring with residual urine measurement. If retention persists, reassess the clinical situation and continue bladder decompression

Published data shows a 92.6% success rate after correction of the underlying etiology of female AUR, so this is a manageable condition with the right specialist approach.
Vous pouvez visiter mon page d'accueil officielle ici.
Frequently Asked Questions About Acute Urinary Retention in Females
Why is acute urinary retention less common in women than men?
Women do not have a prostate gland, which is the most common cause of bladder outlet obstruction in aging men. The female urethra is also shorter and wider, making mechanical obstruction less likely. Literature shows a female-to-male incidence ratio of approximately 1:13 for acute urinary retention. However, when it does occur in women, the etiology is typically complex and multifactorial, requiring thorough specialist evaluation.
What are the most common causes of acute urinary retention in women?
Common acute triggers include the postpartum period (after childbirth) and complications following urological anti-incontinence surgery. Chronic causes include neurogenic bladder dysfunction, underactive detrusor (bladder muscle weakness), gynecological or urethral tumors causing outlet obstruction, and pregnancy. Since causes are often multifactorial, a systematic diagnostic workup by a urologist is essential to identify all contributing factors before initiating treatment.
What is the treatment for acute urinary retention in women?
The immediate treatment is bladder decompression via urethral catheterization or clean intermittent catheterization, which allows the overdistended bladder to rest and recover. The underlying etiology is identified and corrected simultaneously. After 1–14 days of decompression, a voiding trial is performed. Published data shows a 92.6% success rate after well-corrected etiology. If the voiding trial fails, bladder decompression is continued and the clinical situation is reassessed by a specialist.
If you or a family member is experiencing difficulty urinating or has been diagnosed with female urinary retention, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. Prendre rendez-vous.
Avis de non-responsabilité : Ce contenu est rédigé et revu par le Dr Soarawee Weerasopone, urologue certifié au siège de Bangkok Hospital. Il est destiné uniquement à des fins éducatives et ne constitue pas un avis médical. Consultez toujours un professionnel de la santé qualifié avant de commencer tout traitement médical.
Rédigé et révisé par des médecins : Dr. Soarawee Weerasopone (Dr. Pom) – Urologue certifié, Hôpital de Bangkok (siège). Fellowship international : Baylor College of Medicine (États-Unis) · Juntendo University (Japon) · Chang Gung Memorial Hospital (Taïwan).

Le Dr Soarawee Weerasopone (Dr Pom) est un urologue certifié au Bangkok Hospital Headquarters, spécialisé dans la santé masculine, la chirurgie robotique (système Da Vinci) et le traitement des calculs rénaux. Il a effectué des bourses internationales au Baylor College of Medicine (États-Unis), à l'hôpital universitaire Juntendo (Japon) et à l'hôpital commémoratif Chang Gung (Taïwan). Tout le contenu médical de ce site est rédigé et révisé par le Dr Soarawee, sur la base de son expérience clinique et de sa formation internationale.

